Tag: OVER
59.0 Percent of Overdose Deaths Involved Stimulants in 2021 to 2024
People who died of overdoses involving stimulants and no opioids were older, more often had history of CVD
FDA Requiring Stronger Safety Labels for Opioid Medications
Updated opioid safety labeling is based on new data from two large postmarketing observational studies
Drug Overdoses in Health Care Workers Often Involve Drugs Obtained From Workplace
Opioids are most often the drug class implicated in causing death
Increase Seen in Reports of Lidocaine Poisonings and Mortality Since 2010
Following publication of advisories, reports of local anesthetic poisoning decreased, but reports of lidocaine poisoning and mortality increased
Disparities Exist in Outpatient Referrals for Opioid Use Disorder
Findings seen for Black patients presenting to the emergency department
U.S. Drug Overdose Deaths Started Declining in 2023
Monthly DOD rate declined by −0.36 per 100,000 from August 2023 to February 2024, accelerating through October 2024
Youth Deaths Attributable to Synthetic Opioids Alone Increasingly Predominant
Since 2020, fatal synthetic opioid-only overdose rates higher than polydrug overdose rates involving synthetic opioids
Rates of Fentanyl Nonfatal Overdose ED Visits Rose Through Third Quarter of 2023
Trends increased among most demographic groups through mid-2023, with largest increase seen for non-Hispanic American Indian, Alaska Native persons
CDC: Drug Overdose Deaths Down More Than 25 Percent in 2024
Declines seen across drug classes and for most states
Racial Disparities Seen in Unintentional Overdose Mortality
Black men and Black women have pronounced and increasing burden of mortality compared with Whites
